Sanara MedTech Inc.
SMTI
$23.17
-$0.47-1.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.92% | 4.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.92% | 4.60% | |||
| Cost of Revenue | 2.62% | 0.02% | |||
| Gross Profit | 0.79% | 4.95% | |||
| SG&A Expenses | 9.00% | 0.99% | |||
| Depreciation & Amortization | -12.13% | 9.41% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.02% | 5.39% | |||
| Operating Income | -8.47% | -1.69% | |||
| Income Before Tax | 135.92% | -232.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 135.92% | -232.69% | |||
| Earnings from Discontinued Operations | 112.11% | 98.39% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | -80.00% | |||
| Net Income | 128.51% | 94.71% | |||
| EBIT | -8.47% | -1.69% | |||
| EBITDA | -9.16% | -1.27% | |||
| EPS Basic | 127.74% | 94.60% | |||
| Normalized Basic EPS | -47.23% | -10.26% | |||
| EPS Diluted | 124.63% | 94.42% | |||
| Normalized Diluted EPS | -48.89% | -7.19% | |||
| Average Basic Shares Outstanding | 2.76% | -2.01% | |||
| Average Diluted Shares Outstanding | 6.05% | -5.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||